Reported in-stent stenosis (ISS) in different flow diverter (FD) stent devices
| Series | Sample size | FD device | Reported incidence of ISS and intimal hyperplasia, N (%) | Time of follow-up |
| Lubicz et al 5 | 47 | SILK | 27 (57%) | <12 months |
| Berge et al 16 | 64 | SILK | 5 (7.8%) | 6 months |
| Pumar et al 11 | 128 | SILK | 8 (6.3%) | 12 months |
| Cohen et al 7 | 16 | SILK | 6 (37.5%) | 2 months |
| 18 | PED | 7 (38.9%) | 2 months | |
| John et al 6 | 51 | PED | 21 (41.2%) | 6 months |
| McAuliffe8 | 57 | PED | 2 (3.5%) | 6 months |
| Lylyk et al 14 | 38 | PED | 7 (18.4%) | 3 months |
| Aguilar Pérez et al 29 | 223 | p64 | 66 (29.6%) | 3 months |
| Morais et al 12 | 29 | p64 | 9 (31%) | 3 months |
| De Vries et al 13 | 30 | Surpass | 4 (13.3%) | 6 months |
| Drescher et al 30 | 50 | FRED | 3 (6%) | 3 months |